Smith & Nephew confirms interest in Biomet
This article was originally published in Clinica
Orthopaedic company Smith & Nephew confirmed today that it has had preliminary talks with US counterpart Biomet regarding a strategic acquisition. A brief statement issued by the London, UK-based company said that no agreement had been reached. Speculation on a merger of the two companies, to form a combined unit with hip sales of $703m and knee sales of $997m, has been building since the US firm and its CEO Dane Miller parted company this spring.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.